@ Diagnostic Imaging Europe (DI Europe)

AI after deployment: why post-market surveillance matters

Experts at ECR 2026 discussed one of the growing challenges in clinical AI adoption: how to ensure AI tools remain reliable and safe once they enter daily radiology workflows.

IT / AI

Global Perspectives on Remote Radiology in Practice

What can remote radiology mean for patients, radiologists, and healthcare systems with focus on benefits and trade-offs?

Events

Radiology errors in focus: lessons on AI, bias and communication at ECR 2026

Radiology experts at ECR 2026 examined why diagnostic errors occur, how artificial intelligence may affect them, and why open communication with patients remains essential when mistakes happen.

IT / AI

From Scan to Simulation: Applications of Digital Twins

From coronary physiology modeling to adaptive oncology, imaging-driven digital twins are moving into routine clinical workflows.

IT / AI

Bracco at ECR: AI, contrast agents and new paths to more precise imaging

Bracco Imaging showcased AiMIFY® at ECR, an AI-powered MRI contrast enhancement solution developed with Subtle Medical that analyzes brain scans and amplifies existing contrast signals.

Insights

From Scan to Simulation: Applications of Digital Twins

From coronary physiology modeling to adaptive oncology, imaging-driven digital twins are moving into routine clinical workflows.

Global Perspectives on Remote Radiology in Practice

What can remote radiology mean for patients, radiologists, and healthcare systems with focus on benefits and trade-offs?

Advancing Spectral CT: A First Clinical Experience with Philips Verida

Spectral imaging, faster workflows and lower radiation dose are shaping the next generation of CT diagnostics.

ECR 2026: Bracco Showcases AiMIFY

AI-Powered Brain MRI Solution

At this position you may find an embedded video from Vimeo.

When displayed, personal data (such as IP address) is transferred to Vimeo.

Please read Vimeo's privacy policy for detailed information.

Display external content

AI after deployment: why post-market surveillance matters

Experts at ECR 2026 discussed one of the growing challenges in clinical AI adoption: how to ensure AI tools remain reliable and safe once they enter daily radiology workflows.

News

Bayer PET Tracer Hits Phase III Goals in Cardiac Amyloidosis

SimonMed Expands AI-Enhanced MRI with SwiftMR Deployment

Six London NHS Trusts Adopt Sectra One Cloud

CCTA Plaque Quantification Improves Cardiovascular Risk Assessment in Women

Combined OCT and MRI Improve Diagnosis of MINOCA

MRI Combination Marker Shows High Accuracy in Cervical Cancer Grading

Catalyst MedTech Expands Brain PET Implementation in the U.S.

Premier Radiology Expands Teleradiology with GLOBIS Acquisition

Diagnoly Expands Fetal Ultrasound AI with iOS Launch

Philips Expands Cloud-Based Digital Pathology Portfolio

Clatterbridge Installs PET-CT System to Cut Scan Times

SHERPA Clinical Studies on AI Support for Radiology

Japan Approves Low-Dose MRI Contrast Agent Ambelvist

FDA Clears GE HealthCare’s View Diagnostic Viewer

Detection Technology Introduces X-ACE HS Detectors for Next-Generation CT

Medimaps and Radiobotics Merge to Expand MSK Imaging AI

UChicago Medicine Expands Neurosurgery With Intraoperative MRI

DeepHealth Secures CE Mark for TechLive Remote Imaging Platform

Esaote Unveiled New Ultrasound Systems and AI Imaging Tools at ECR 2026

Bayer Presents New Data for Contrast Agent Gadoquatrane from Phase III Program at ECR 2026

Insights

Siemens Healthineers Showcases Imaging Innovations at RSNA 2025

New systems aim to improve lesion visibility, workflow efficiency, and interventional imaging capabilities

Photo: Bayer Spotlights Next-Generation MRI and Low-Dose Contrast Agent...

Bayer Spotlights Next-Generation MRI and Low-Dose Contrast Agent Gadoquatrane at ECR 2026

At European Congress of Radiology (ECR) 2026, Bayer highlighted new developments in MRI technologies and contrast agents aimed at improving diagnostic efficiency and patient care.